Yun-xuan Li

发表

The cell cycle inhibitor P21 promotes the development of pulmonary fibrosis by suppressing lung alveolar regeneration

Zhuo-wei Hu, Fang Hua, Ke Li, 2021, Acta pharmaceutica Sinica. B.

The chemokine CCL1 triggers an AMFR-SPRY1 pathway that promotes differentiation of lung fibroblasts into myofibroblasts and drives pulmonary fibrosis.

Yang Xiao, Zhiguang Zhou, Zhuo-wei Hu, 2021, Immunity.

Targeting Degradation of the Transcription Factor C/EBPβ Reduces Lung Fibrosis by Restoring Activity of the Ubiquitin-Editing Enzyme A20 in Macrophages.

Zhuo-wei Hu, Fang Hua, Ke Li, 2019, Immunity.

TRIB3 promotes pulmonary fibrosis through inhibiting SLUG degradation by physically interacting with MDM2

Fang Hua, Ke Li, B. Cui, 2023, Acta pharmaceutica Sinica. B.

Targeting HDAC3 to overcome the resistance to ATRA or arsenic in acute promyelocytic leukemia through ubiquitination and degradation of PML-RARα

Jun Yu Li, Jiong Hu, A. Liang, 2022, Cell Death & Differentiation.

Identification of N, C-capped di- and tripeptides as selective immunoproteasome inhibitors.

Zhiyan Xiao, Ying Yang, Yun-xuan Li, 2022, European journal of medicinal chemistry.

The chemokine CCL1 triggers an AMFR-SPRY1 pathway that promotes differentiation of lung fibroblasts into myofibroblasts and drives pulmonary fibrosis.

Yang Xiao, Zhiguang Zhou, Zhuo-wei Hu, 2021, Immunity.

SCARB2 drives hepatocellular carcinoma tumor initiating cells via enhanced MYC transcriptional activity

Yang Gao, Feng Wang, Jian Yuan, 2023, Nature communications.

Targeting HDAC3 to overcome the resistance to ATRA or arsenic in acute promyelocytic leukemia through ubiquitination and degradation of PML-RARα

Jun Yu Li, Jiong Hu, A. Liang, 2023, Cell Death & Differentiation.